FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2024305801> ?p ?o ?g. }

• W2024305801 endingPage "18" @default.
• W2024305801 startingPage "12" @default.
• W2024305801 abstract "Background: Combination vaccines against common childhood diseases are widely used, provide an improved coverage, are more convenient and are more cost-effective than multiple injections. We conducted a study to evaluate the safety and immunogenicity of acombined measles-mumps-rubella-varicella (MMRV) candidate vaccine in comparison with the separate administration of licensed measles-mumps-rubella (MMR; Priorix) and varicella (V; Varilrix) vaccines. Methods: Healthy children 12–18 months of age received 2 doses of MMRV vaccine (3 lots) 6–8 weeks apart (MMRV group) or 1 dose of MMR vaccine administered concomitantly with 1 dose of varicella vaccine, followed by a second dose of MMR at 6–8 weeks later (MMR+V group). Local symptoms (redness, pain and swelling) were recorded for 4 days after vaccination, and fever (any, axillary temperature ≥37.5°C or rectal temperature ≥38.0°C; grade 3, axillary temperature >39.0°C or rectal temperature >39.5°C) was monitored daily for 15 days. Other adverse events were monitored for 6 weeks. Results: A total of 494 children were vaccinated (371 in the MMRV group and 123 in the MMR+V group. Two doses of MMRV vaccine were at least as immunogenic as 2 doses of MMR and 1 dose of varicella vaccine. After the second dose, all children had seroconverted to measles, rubella and varicella in both vaccine groups, and 98% versus 99% had seroconverted to mumps in the MMRV versus the MMR+V group, respectively. The MMRV vaccine did not induce an increased local or general reactogenicity compared with the separate administration, although a higher incidence of low grade fever was seen after the first dose in the MMRV group (67.7% after MMRV versus 48.8% after MMR+V; P < 0.05), this was not observed for grade 3 fever (11.6% after MMRV versus 10.6% after MMR+V; P = 0.87). After the second dose, no differences in incidence of fever were found in either MMRV or MMR+V groups. Conclusion: Administration of 2 doses of the combined MMRV vaccine was as immunogenic and well-tolerated as separate injections of MMR and varicella vaccine." @default.
• W2024305801 created "2016-06-24" @default.
• W2024305801 creator A5002387175 @default.
• W2024305801 creator A5014193186 @default.
• W2024305801 creator A5014279304 @default.
• W2024305801 creator A5017838321 @default.
• W2024305801 creator A5024245378 @default.
• W2024305801 creator A5029016622 @default.
• W2024305801 creator A5036426998 @default.
• W2024305801 creator A5040139497 @default.
• W2024305801 creator A5042291025 @default.
• W2024305801 creator A5044659175 @default.
• W2024305801 creator A5068331645 @default.
• W2024305801 creator A5076584713 @default.
• W2024305801 date "2006-01-01" @default.
• W2024305801 modified "2023-09-26" @default.
• W2024305801 title "Immunogenicity and Safety of Two Doses of Tetravalent Measles-Mumps-Rubella-Varicella Vaccine in Healthy Children" @default.
• W2024305801 cites W1540527321 @default.
• W2024305801 cites W1603398248 @default.
• W2024305801 cites W1640344850 @default.
• W2024305801 cites W1693650742 @default.
• W2024305801 cites W1835136536 @default.
• W2024305801 cites W1959448710 @default.
• W2024305801 cites W1970769167 @default.
• W2024305801 cites W1973000833 @default.
• W2024305801 cites W1980121967 @default.
• W2024305801 cites W1981159087 @default.
• W2024305801 cites W1982608076 @default.
• W2024305801 cites W2017451726 @default.
• W2024305801 cites W2061684539 @default.
• W2024305801 cites W2070438008 @default.
• W2024305801 cites W2074281239 @default.
• W2024305801 cites W2078455247 @default.
• W2024305801 cites W2103764028 @default.
• W2024305801 cites W2106450984 @default.
• W2024305801 cites W2121723554 @default.
• W2024305801 cites W2142105274 @default.
• W2024305801 cites W2161014948 @default.
• W2024305801 cites W2333616291 @default.
• W2024305801 cites W2767633309 @default.
• W2024305801 cites W4256299010 @default.
• W2024305801 doi "https://doi.org/10.1097/01.inf.0000195626.35239.58" @default.
• W2024305801 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/16395096" @default.
• W2024305801 hasPublicationYear "2006" @default.
• W2024305801 type Work @default.
• W2024305801 sameAs 2024305801 @default.
• W2024305801 citedByCount "94" @default.
• W2024305801 countsByYear W20243058012012 @default.
• W2024305801 countsByYear W20243058012013 @default.
• W2024305801 countsByYear W20243058012014 @default.
• W2024305801 countsByYear W20243058012015 @default.
• W2024305801 countsByYear W20243058012016 @default.
• W2024305801 countsByYear W20243058012017 @default.
• W2024305801 countsByYear W20243058012018 @default.
• W2024305801 countsByYear W20243058012019 @default.
• W2024305801 countsByYear W20243058012020 @default.
• W2024305801 countsByYear W20243058012021 @default.
• W2024305801 countsByYear W20243058012023 @default.
• W2024305801 crossrefType "journal-article" @default.
• W2024305801 hasAuthorship W2024305801A5002387175 @default.
• W2024305801 hasAuthorship W2024305801A5014193186 @default.
• W2024305801 hasAuthorship W2024305801A5014279304 @default.
• W2024305801 hasAuthorship W2024305801A5017838321 @default.
• W2024305801 hasAuthorship W2024305801A5024245378 @default.
• W2024305801 hasAuthorship W2024305801A5029016622 @default.
• W2024305801 hasAuthorship W2024305801A5036426998 @default.
• W2024305801 hasAuthorship W2024305801A5040139497 @default.
• W2024305801 hasAuthorship W2024305801A5042291025 @default.
• W2024305801 hasAuthorship W2024305801A5044659175 @default.
• W2024305801 hasAuthorship W2024305801A5068331645 @default.
• W2024305801 hasAuthorship W2024305801A5076584713 @default.
• W2024305801 hasConcept C159047783 @default.
• W2024305801 hasConcept C159654299 @default.
• W2024305801 hasConcept C187212893 @default.
• W2024305801 hasConcept C203014093 @default.
• W2024305801 hasConcept C22070199 @default.
• W2024305801 hasConcept C2776438120 @default.
• W2024305801 hasConcept C2776646718 @default.
• W2024305801 hasConcept C2777704310 @default.
• W2024305801 hasConcept C2778814567 @default.
• W2024305801 hasConcept C2780473352 @default.
• W2024305801 hasConcept C2780801004 @default.
• W2024305801 hasConcept C2780868878 @default.
• W2024305801 hasConcept C2909545207 @default.
• W2024305801 hasConcept C71924100 @default.
• W2024305801 hasConceptScore W2024305801C159047783 @default.
• W2024305801 hasConceptScore W2024305801C159654299 @default.
• W2024305801 hasConceptScore W2024305801C187212893 @default.
• W2024305801 hasConceptScore W2024305801C203014093 @default.
• W2024305801 hasConceptScore W2024305801C22070199 @default.
• W2024305801 hasConceptScore W2024305801C2776438120 @default.
• W2024305801 hasConceptScore W2024305801C2776646718 @default.
• W2024305801 hasConceptScore W2024305801C2777704310 @default.
• W2024305801 hasConceptScore W2024305801C2778814567 @default.
• W2024305801 hasConceptScore W2024305801C2780473352 @default.
• W2024305801 hasConceptScore W2024305801C2780801004 @default.
• W2024305801 hasConceptScore W2024305801C2780868878 @default.
• W2024305801 hasConceptScore W2024305801C2909545207 @default.

• next